JP2015129652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015129652A5 JP2015129652A5 JP2014000417A JP2014000417A JP2015129652A5 JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5 JP 2014000417 A JP2014000417 A JP 2014000417A JP 2014000417 A JP2014000417 A JP 2014000417A JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence shown
- peptide consisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 24
- 206010008118 Cerebral infarction Diseases 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
Description
本発明にかかる脳梗塞の診断マーカーは、配列番号113に示すアミノ酸配列からなるペプチド、配列番号79に示すアミノ酸配列からなるペプチド、配列番号57に示すアミノ酸配列からなるペプチド、配列番号63に示すアミノ酸配列からなるペプチド、及び、配列番号171に示すアミノ酸配列からなるペプチドの少なくとも何れか１つを含むことを特徴とする。
The diagnostic marker for cerebral infarction according to the present invention includes a peptide consisting of the amino acid sequence shown in SEQ ID NO: 113, a peptide consisting of the amino acid sequence shown in SEQ ID NO: 79, a peptide consisting of the amino acid sequence shown in SEQ ID NO: 57, and an amino acid shown in SEQ ID NO: 63 It includes at least one of a peptide consisting of the sequence and a peptide consisting of the amino acid sequence shown in SEQ ID NO: 171 .
本発明にかかる脳梗塞の診断キットは、配列番号113に示すアミノ酸配列からなるペプチド、配列番号79に示すアミノ酸配列からなるペプチド、配列番号57に示すアミノ酸配列からなるペプチド、配列番号63に示すアミノ酸配列からなるペプチド、及び、配列番号171に示すアミノ酸配列からなるペプチドの少なくとも何れか１つを含むことを特徴とする。
The diagnostic kit for cerebral infarction according to the present invention comprises a peptide consisting of the amino acid sequence shown in SEQ ID NO: 113, a peptide consisting of the amino acid sequence shown in SEQ ID NO: 79, a peptide consisting of the amino acid sequence shown in SEQ ID NO: 57, and an amino acid shown in SEQ ID NO: 63 It includes at least one of a peptide consisting of the sequence and a peptide consisting of the amino acid sequence shown in SEQ ID NO: 171 .
Claims (4)
配列番号79に示すアミノ酸配列からなるペプチド、
配列番号57に示すアミノ酸配列からなるペプチド、
配列番号63に示すアミノ酸配列からなるペプチド、及び、
配列番号171に示すアミノ酸配列からなるペプチドの少なくとも何れか１つを含むことを特徴とする脳梗塞の診断マーカー。 A peptide consisting of the amino acid sequence shown in SEQ ID NO: 113,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 79,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 57 ,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 63 , and
A diagnostic marker for cerebral infarction, comprising at least one peptide selected from the amino acid sequence shown in SEQ ID NO: 171 .
配列番号79に示すアミノ酸配列からなるペプチド、
配列番号57に示すアミノ酸配列からなるペプチド、
配列番号63に示すアミノ酸配列からなるペプチド、及び、
配列番号171に示すアミノ酸配列からなるペプチドの少なくとも何れか１つを含むことを特徴とする脳梗塞の診断キット。 A peptide consisting of the amino acid sequence shown in SEQ ID NO: 113,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 79,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 57 ,
A peptide consisting of the amino acid sequence shown in SEQ ID NO: 63 , and
A diagnostic kit for cerebral infarction, comprising at least one peptide selected from the amino acid sequence shown in SEQ ID NO: 171 .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014000417A JP6312302B2 (en) | 2014-01-06 | 2014-01-06 | Diagnostic marker for cerebral infarction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014000417A JP6312302B2 (en) | 2014-01-06 | 2014-01-06 | Diagnostic marker for cerebral infarction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018050502A Division JP6499342B2 (en) | 2018-03-19 | 2018-03-19 | Diagnostic marker for cerebral infarction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015129652A JP2015129652A (en) | 2015-07-16 |
| JP2015129652A5 true JP2015129652A5 (en) | 2017-06-22 |
| JP6312302B2 JP6312302B2 (en) | 2018-04-18 |
Family
ID=53760486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014000417A Active JP6312302B2 (en) | 2014-01-06 | 2014-01-06 | Diagnostic marker for cerebral infarction |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6312302B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6942036B2 (en) * | 2017-11-30 | 2021-09-29 | 藤倉化成株式会社 | Body fluid antibody biomarker that detects the risk of developing cerebral infarction with high sensitivity |
| CN114594273B (en) * | 2022-05-09 | 2024-02-27 | 上海众启生物科技有限公司 | Cerebral infarction biomarker and application thereof |
| CN115261457B (en) * | 2022-06-13 | 2023-10-27 | 广州市妇女儿童医疗中心 | Marker combination for auxiliary diagnosis of cerebral infarction and prognosis evaluation thereof, kit containing marker combination and application of kit |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4070443B2 (en) * | 2001-10-11 | 2008-04-02 | 株式会社三菱化学ヤトロン | How to detect cerebral infarction |
| GB0911060D0 (en) * | 2009-06-26 | 2009-08-12 | Ge Healthcare Uk Ltd | Methods for predicting the toxicity of a chemical |
| US20120040858A1 (en) * | 2010-08-13 | 2012-02-16 | Morehouse School Of Medicine | Biomarkers for stroke |
| EP2628013B1 (en) * | 2010-10-14 | 2019-06-12 | The Johns Hopkins University | Biomarkers of brain injury |
| GB2497138A (en) * | 2011-12-02 | 2013-06-05 | Randox Lab Ltd | Biomarkers for stroke and stroke subtype diagnosis. |
| KR20140145173A (en) * | 2012-03-26 | 2014-12-22 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | Cellular markers for diagnosis of Alzheimer's disease and for alzheimer's disease progression |
-
2014
- 2014-01-06 JP JP2014000417A patent/JP6312302B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017048194A5 (en) | ||
| WO2017011820A3 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| JP2013172734A5 (en) | ||
| WO2016115168A8 (en) | Incorporation of unnatural nucleotides and methods thereof | |
| MX2018001213A (en) | Novel methods for inducing an immune response. | |
| MX2017009595A (en) | Anti-senescence compounds and uses thereof. | |
| WO2016115320A8 (en) | Nucleic acid nanostructures with core motifs | |
| SG11201702748TA (en) | Lepidopteran-active cry1da1 amino acid sequence variant proteins | |
| IL250646A0 (en) | Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of peg | |
| WO2015107363A3 (en) | Mycobacterial antigen composition | |
| JP2010265269A5 (en) | ||
| WO2015185758A3 (en) | Preparation comprising factor viii and von willebrand factor peptides | |
| DOP2016000202A (en) | UTI FUSION PROTEINS | |
| WO2016070206A8 (en) | Polypeptide for the enzymatic detoxification of zearalenone, isolated polynucleotide, and associated additive, use and method | |
| JP2015129652A5 (en) | ||
| CU20170038A7 (en) | DERIVATIVES OF ADRENOMEDULIN STABILIZED ESPECIALLY USEFUL IN THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR, EDEMATOS AND / OR INFLAMMATORY DISORDERS | |
| WO2015132397A3 (en) | Mitochondrial preproteins as markers for alzheimer's disease | |
| ES2609993B1 (en) | Peptide for the treatment of allergy | |
| WO2016205522A3 (en) | Antibodies recognizing phosphorylation at specific amino acid residues of transactive response dna-binding protein 43 | |
| GB2526222A (en) | Viral peptides | |
| TH168562B (en) | Nucleic Acids and Methods for the Detection of Pathogens and Beneficial Microorganisms | |
| TH168562A (en) | Nucleic Acids and Methods for the Detection of Pathogens and Beneficial Microorganisms | |
| RU2016146358A (en) | Cholinergic inhibitor | |
| TH168983A (en) | Cationic Neurotoxins | |
| Win | The Yati (Vol 11 No 128) 2014/11 |